Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
102.60    -1.90 (-1.82%)
Bid:
101.90
Ask:
102.50
Spread: 0.60 (0.589%)
Market Cap: £380.81m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

Response to BPEA's Statement

16 May 2022 07:38

RNS Number : 5882L
RWS Holdings PLC
16 May 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

16 May 2022

 

RWS Holdings plc

("RWS" or the "Company")

 

RESPONSE TO BPEA'S STATEMENT THAT IT IS NO LONGER EVALUATING A POSSIBLE OFFER FOR RWS

 

RWS notes today's announcement made by Baring Private Equity Asia Fund VIII Limited ("BPEA") that it is no longer evaluating a possible offer for the Company and that it is consequently bound by the restrictions under Rule 2.8 of the City Code on Takeovers and Mergers. 

 

The interest from BPEA was unsolicited and did not result in any proposal being made to RWS. The Board of RWS believes the Company has a strong future based on its clearly defined strategy, as outlined at its Capital Markets Event on 23 March 2022, which includes accelerating organic growth, capitalising on a simplified technology portfolio, driving operational leverage and enhancing growth and returns. The Company is focused on the actions and investments which support this strategy and its five year accelerated growth plan. The Board believes the delivery of this strategy will create significant value for the Company's shareholders.

 

RWS will report its results for the six months ended 31 March 2022 on 9 June 2022.

 

This announcement is not being made with the consent of BPEA.

 

Enquiries:

RWS Holdings plcAndrew Brode, Chairman

Ian El-Mokadem, Chief Executive Officer

Rod Day, Chief Financial Officer

01753 480200

 

 

Gleacher Shacklock (Financial Adviser to RWS)

Dominic Lee

Tom Quinn

020 7484 1150

 

 

Goldman Sachs International (Financial Adviser to RWS)

Khamran AliOwain Evans

 

020 7774 1000

 

 

Numis Securities Limited (Nomad & Joint Broker) Stuart Skinner

Kevin Cruickshank

 

020 7260 1000

 

Berenberg (Joint Broker)Ben Wright

Toby Flaux

020 3207 7800

 

 

MHPKatie HuntSimon Hockridge

rws@mhpc.com

020 3128 8789

 

 

About RWS RWS Holdings plc is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our unique combination of technology and cultural expertise helps our clients to grow by ensuring they are understood anywhere, in any language.

 

Our purpose is unlocking global understanding. By combining cultural understanding, client understanding and technical understanding, our services and technology assist our clients to acquire and retain customers, deliver engaging user experiences, maintain compliance and gain actionable insights into their data and content.

 

Our clients include 90 of the world's top 100 brands, the top 20 pharmaceutical companies and 19 of the top 20 patent filers. Our client base spans Europe, Asia Pacific and North and South America. We work in the automotive, chemical, financial, legal, medical, pharmaceutical, technology and telecommunications sectors, which we serve from 80+ global locations across five continents.

 

Founded in 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L).

 

For further information, please visit: www.rws.com.

Important notices

 

Gleacher Shacklock LLP ("Gleacher Shacklock"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for RWS and no one else in connection with the matters set out in this announcement and will not be responsible to anyone other than RWS for providing the protections offered to clients of Gleacher Shacklock or for providing advice in relation to the contents of this announcement or any matters referred to herein.

 

Goldman Sachs International ("Goldman Sachs"), which is authorised by the Prudential Regulation Authority and regulated in the United Kingdom by the Financial Conduct Authority and the Prudential Regulation Authority, is acting exclusively for RWS and no one else in connection with the matters set out in this announcement and will not be responsible to anyone other than RWS for providing the protections offered to clients of Goldman Sachs or for providing advice in relation to the contents of this announcement or any matters referred to herein.

 

Numis Securities Limited ("Numis"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for RWS and no one else in connection with the matters set out in this announcement and will not be responsible to anyone other than RWS for providing the protections offered to clients of Numis or for providing advice in relation to the contents of this announcement or any matters referred to herein.

 

Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), which is regulated by the German Federal Financial Supervisory Authority (BaFin) and subject to limited regulation in the United Kingdom by the Financial Conduct Authority, is acting exclusively for RWS and no one else in connection with the matters set out in this announcement and will not be responsible to anyone other than RWS for providing the protections offered to clients of Berenberg or for providing advice in relation to the contents of this announcement or any matters referred to herein.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RSPFIFFRETIRLIF
Date   Source Headline
9th Jan 20259:10 amRNSPublication of Annual Report and Notice of AGM
6th Jan 20259:00 amRNSAppointment of Director
2nd Jan 20257:00 amRNSTotal Voting Rights
12th Dec 20247:00 amRNSFinal Results
2nd Dec 20247:00 amRNSTotal Voting Rights
26th Nov 20247:00 amRNSDirectorate Change
1st Nov 20247:00 amRNSTotal Voting Rights
31st Oct 202410:12 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSTrading Statement
1st Oct 20247:00 amRNSDirectorate Change
1st Oct 20247:00 amRNSTotal Voting Rights
24th Sep 20247:00 amRNSDirector/PDMR Shareholding
2nd Sep 20247:00 amRNSTotal Voting Rights
13th Aug 202411:15 amRNSHolding(s) in Company
1st Aug 20249:21 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTotal Voting Rights
21st Jun 20249:58 amRNSDirector/PDMR Shareholding
12th Jun 20249:50 amRNSDirector/PDMR Shareholding
12th Jun 20247:00 amRNSHalf-year Report
3rd Jun 20247:00 amRNSTotal Voting Rights
23rd May 20247:00 amRNSDirectorate Change
1st May 20247:00 amRNSTotal Voting Rights
23rd Apr 20247:00 amRNSTrading Statement
2nd Apr 20247:00 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTotal Voting Rights
23rd Feb 20247:00 amRNSHolding(s) in Company
22nd Feb 20241:01 pmRNSResult of AGM
22nd Feb 20247:00 amRNSClosing of Share Repurchase Programme
22nd Feb 20247:00 amRNSAGM Statement
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20249:33 amRNSHolding(s) in Company
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTotal Voting Rights
1st Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20248:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.